| E-3810 |
|
| (CAS 1058137-23-7) |
 |
| Description： |
E-3810 is a novel dual inhibitor targeting human vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs) with antiangiogenic activity.
VEGFR/FGFR dual kinase inhibitor E-3810 inhibits VEGFR-1, -2, -3 and FGFR-1, -2 kinases in the nM range, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation, and the induction of tumor cell death. Both VEGFRs and FGFRs belong to the family of receptor tyrosine kinases that may be upregulated in various tumor cell types.
|
| Product No. |
KT00140 |
| Product Name |
E-3810 |
| Synonyms |
Lucitanib |
| Formal Name |
|
| CAS Number |
1058137-23-7 |
| Molecular Formula |
C26H25N3O4 |
| Formula Weight |
443.49 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
Apatinib
Axitinib
AZD2932
AZD4547
BIBF 1120
BMS-690514
Brivanib
Cediranib
E-7050
EG00229
|
|
